Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 Diabetes
Clinical trial NCT03226210 · COMPLETED
Trial details
- NCT number
- NCT03226210
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-05-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.